We are also planning to venture into other healthcare and medical device-related ventures and explore the possibility of listing our manufacturing division separately from the group to further unlock its value in the future,” said Leong.
Look like sinopharma local share holders is mashing !!!!! I won't be surprised the sino vaccine will be packed in mashing factory !!? Soon the old fox will write good about mashing !!!!!!!!!!
The 10,000 doses of Sinopharm Vaccine to be sponsored is by GI Healthcare Resources Sdn Bhd is merely to fulfill their corporate social responsibility (CSR) to donate 10,000 doses of Sinopharm Vaccine for emergency use of frontliners only, NOT FOR GENERAL PUBLIC. They will not be distributing the vaccines.
Please note that Emergency use is NOT the same as full approval. It is merely a form of conditional authorization of the vaccine to be used by specific targeted groups such as frontliners and vulnerable groups ONLY (and NOT FOR GENERAL PUBLIC). Emergency use authorization is just based on interim clinical trial results (pending the completion of phase III clinical trial). Once the phase III clinical trial of Sinopharm Vaccine is completed very soon, the complete clinical data of the vaccine can then be submitted to the Ministry of Health (MOH) for evaluation and approval. Upon receiving FULL APPROVAL of the vaccine by Ministry of Health (MOH), the vaccine can then be used for the GENERAL PUBLIC.
Kanger in collaboration with Zuellig Pharma and Kstar will be the ones distributing the vaccines to private and government hospitals and clinics.
Sinopharm JV with GI Healthcare to sponsor 10,000 doses to Frontliners.
Mah Sing involved via GI Healthcare?
KUALA LUMPUR (Nov 17): China National Pharmaceutical Group (Sinopharm), through GI Healthcare Resources Sdn Bhd — a joint-venture company (JVCo) with local investors — has agreed to sponsor 10,000 doses of the former's Covid-19 vaccine for Malaysian frontliners.
The sponsorship was agreed upon yesterday via a meeting between Malaysian officials, led by Home Minister Datuk Seri Hamzah Zainuddin and Health Minister Datuk Dr Adham Baba, and Sinopharm's chairman Liu Jingzhen via video conferencing.
Meanwhile, GI Healthcare Resources was represented by Tan Sri Lim Yew Loong, Tan Sri Leong Hoy Kum, Sim Guan Yu and Rosli Dahlan as its advisers while Liu represented the firm in the video conference.
This week very good one glove per market value very cheap, next week not yet produce single glove. next year donate few million to charity ppl compliment he as a philantrophis.
The 10,000 doses of Sinopharm Vaccine to be sponsored is by GI Healthcare Resources Sdn Bhd is merely to fulfill their corporate social responsibility (CSR) to donate 10,000 doses of Sinopharm Vaccine for emergency use of frontliners only, NOT FOR GENERAL PUBLIC. They will not be distributing the vaccines.
Please note that Emergency use is NOT the same as full approval. It is merely a form of conditional authorization of the vaccine to be used by specific targeted groups such as frontliners and vulnerable groups ONLY (and NOT FOR GENERAL PUBLIC). Emergency use authorization is just based on interim clinical trial results (pending the completion of phase III clinical trial). Once the phase III clinical trial of Sinopharm Vaccine is completed very soon, the complete clinical data of the vaccine can then be submitted to the Ministry of Health (MOH) for evaluation and approval. Upon receiving FULL APPROVAL of the vaccine by Ministry of Health (MOH), the vaccine can then be used for the GENERAL PUBLIC.
Kanger in collaboration with Zuellig Pharma and Kstar will be the ones distributing the vaccines to private and government hospitals and clinics.
Existing plastic factory fully converted into healthcare product manufacturing, using the latest robotic machine for producing superb quality nitrile medical gloves. 1st qtr 2021 will be 5th largest gloves company, 2012 over take kossan 4th position !!! Just wait for old fox make up a beautiful write up next week provided he collected enough lah !!!
KUALA LUMPUR (Nov 17): China National Pharmaceutical Group (Sinopharm), through GI Healthcare Resources Sdn Bhd — a joint-venture company (JVCo) with local investors —GI healthcare distributor vaksin untuk goverment malaysia
@Fantaghiro123 Not to worry even if Mah Sing is not involved in vaccine as they have diversified into gloves. They will bounce back up next year after vaccines have been rolled out.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
stkoay
6,490 posts
Posted by stkoay > 2020-11-18 21:29 | Report Abuse
https://www.theedgemarkets.com/article/sinopharm-jvco-sponsor-10000-doses-covid19-vaccine-front-liners
MahSing Health to be distributor for China vaccine ??